MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
19.90
-0.09 (-0.45%)
At close: Jun 26, 2026, 4:00 PM EDT
20.25
+0.35 (1.76%)
After-hours: Jun 26, 2026, 7:46 PM EDT

MLTX Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for MLTX stock have an average target of 30.69, with a low estimate of 6.00 and a high estimate of 70. The average target predicts an increase of 54.22% from the current stock price of 19.90.

Analyst Consensus: Buy
Target Low Average Median High
Price $6.00 $30.69 $30 $70
Change -69.85% +54.22% +50.75% +251.76%

Analyst Ratings

The average analyst rating for MLTX stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 9911111010
Buy 111111
Hold 432222
Sell 000000
Strong Sell 332222
Total 171616161515

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$45
Buy Reiterates $45 +126.13% Jun 24, 2026
Unknown Analyst
Guggenheim
No rating
Guggenheim
Buy
Reiterates
$40
Buy Reiterates $40 +101.01% Jun 23, 2026
BTIG
BTIG
Buy
Maintains
$30
Buy Maintains $30 +50.75% Jun 23, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$33
Buy Maintains $33 +65.83% Jun 22, 2026
Clear Street
Clear Street
Buy
Maintains
$70
Buy Maintains $70 +251.76% Jun 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
19.44M
EPS This Year
-3.86
from -3.53
EPS Next Year
-3.45
from -3.86
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
------19.44M
Revenue Growth
-------
EPS
-8.21-1.70-0.73-1.89-3.53-3.92-3.62
EPS Growth
-------
Forward PE
-------
No. Analysts -----1313
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High n/a 41.5M
Avg n/a 19.4M
Low n/a n/a

Revenue Growth

Revenue Growth 20272028
High -
1,187.8%
Avg -
644.1%
Low -
-29.2%

EPS Forecast

EPS 202620272028
High -3.25 -2.90
Avg -3.86 -3.45
Low -5.16 -4.56

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.